Skip to content
Research Article Open access CC BY 4.0

GBS, Breaking the Stereotypes of Clinicians’ Minds: A Case Study of Atypical Presentation of GBS, Caused by COVID-19 Vaccination?

Rabia Arshad, Zoha Fatima, Ujala Abdul Rashid, Umara Nasim

Asian Journal of Case Reports in Medicine and Health · pp. 160–166 · Published 22 Sep 2022

Abstract

The clinicopathologic spectrum of Guillain Barré Syndrome (GBS) has expanded to include both inflammatory injuries that lead to demyelination and axonal loss forms that cause the motor and sensory loss. However, GBS may also have atypical presentations, that intrigue the clinicians’ interest. COVID-19 vaccines and their adverse effects are an emerging topic in medicine. While GBS has been reported as a rare complication of COVID-19 infection as well as after the meningococcus, influenza, polio, and rabies vaccine; a definitive association with the COVID-19 vaccine is yet to be established.

Guillain Barré Syndrome (GBS) COVID-19 vaccine pandemic

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.